Follow the progress
510 Teams participating
$ 2 311 303 Donation collected
4038 Participants

Give & Win+ Contest: Donate and get a chance to take to the skies with Air Canada! ✈️ 

Fondation Charles-Bruneau

Fondation Charles-Bruneau

What is Fondation Charles-Bruneau?

The Fondation Charles-Bruneau is engaged in the fight against pediatric cancer by working to ensure that all affected children are given the best possible chance of being cured. To achieve this, the Fondation Charles-Bruneau invests in and supports research as well as the development of innovative and promising projects dedicated to pediatric hemato-oncology in Québec.

Did you know?

  • Every day, in Québec, a child is diagnosed with cancer. 
  • More than 2/3 of children treated for cancer will live with after-effects or complications following treatment, once cured.
  • Since 1980, the rate of overall recovery from the main types of cancer has increased from 30% to over 80%.

Where do your donations go?

Benjamin Saine

Owing to advances in research, they lead to a cure, and reduce the side effects of treatment, for more than 80% of children who get cancer.

 

 

 

Projets de recherche

They give researchers the means to achieve their ambitions by funding promising research projects that give hope to the families of children whose cancer is resistant to current treatments.

Équipements, des installations à la fine pointe et des plateformes technologiques

They finance the acquisition of equipment, cutting-edge facilities, and technological platforms that speed the benefits of research to the patient's bedside.

Thérapie par les arts

They help fund the art therapy program, which alleviates stress and helps afflicted children, as well as their siblings, to express the emotions they feel during treatments.

Marie-soleil

They fund projects that enable the development of targeted therapies that maximize recovery and minimize the long-term sequelae of treatment.

 

 

Pharmacie satellite

They fund a satellite pharmacy service that facilitates access to medication for the families of hemato-oncology patients seen in the outpatient clinic.